Adeona Pharmaceuticals Inc., of Ann Arbor, Mich., said that it has completed an equity financing of $1 milion with a single institutional investor, Seaside 88 LP. The financing involved the sale of 1,212,121 registered shares of common stock and no warrants. Enclave Capital served as placement agent and will receive a 7 percent cash commission and five-year warrants to acquire 60,606 shares of Adeona at $1.32 per share. The use of proceeds is intended for general corporate purposes. Separately, Adeona reported the completion of 75 percent enrollment in the second part of Adeona's 60-patient clinical study of oral Zinthionein ZC for Alzheimer's disease and mild cognitive impairment.